Adenosine receptors as targets for therapeutic intervention

B. Suvarna

Research output: Contribution to journalArticle

2 Citations (Scopus)

Abstract

Adenosine receptors are major targets of caffeine, the most commonly consumed drug in the world. There is growing evidence that they could also be promising therapeutic targets in a wide range of conditions, including cerebral and cardiac ischaemic diseases, sleep disorders, immune and inflammatory disorders and cancer. After more than three decades of medicinal chemistry research, a considerable number of selective agonists and antagonists of adenosine receptors have been discovered, and some have been clinically evaluated, although none has yet received regulatory approval. However, recent advances in the understanding of the roles of the various adenosine receptor subtypes, and in the development of selective and potent ligands, as discussed in this review, have brought the goal of therapeutic application of adenosine receptor modulators considerably closer.

Original languageEnglish
Pages (from-to)96-101
Number of pages6
JournalKathmandu University Medical Journal
Volume11
Issue number41
Publication statusPublished - 01-01-2013
Externally publishedYes

Fingerprint

Purinergic P1 Receptors
Purinergic P1 Receptor Agonists
Purinergic P1 Receptor Antagonists
Pharmaceutical Chemistry
Immune System Diseases
Caffeine
Heart Diseases
Therapeutics
Ligands
Research
Pharmaceutical Preparations
Neoplasms

All Science Journal Classification (ASJC) codes

  • Medicine(all)

Cite this

@article{5a4e29d902bd42c8a76cb0ab48661eca,
title = "Adenosine receptors as targets for therapeutic intervention",
abstract = "Adenosine receptors are major targets of caffeine, the most commonly consumed drug in the world. There is growing evidence that they could also be promising therapeutic targets in a wide range of conditions, including cerebral and cardiac ischaemic diseases, sleep disorders, immune and inflammatory disorders and cancer. After more than three decades of medicinal chemistry research, a considerable number of selective agonists and antagonists of adenosine receptors have been discovered, and some have been clinically evaluated, although none has yet received regulatory approval. However, recent advances in the understanding of the roles of the various adenosine receptor subtypes, and in the development of selective and potent ligands, as discussed in this review, have brought the goal of therapeutic application of adenosine receptor modulators considerably closer.",
author = "B. Suvarna",
year = "2013",
month = "1",
day = "1",
language = "English",
volume = "11",
pages = "96--101",
journal = "Kathmandu University Medical Journal",
issn = "1812-2027",
publisher = "Kathmandu University",
number = "41",

}

Adenosine receptors as targets for therapeutic intervention. / Suvarna, B.

In: Kathmandu University Medical Journal, Vol. 11, No. 41, 01.01.2013, p. 96-101.

Research output: Contribution to journalArticle

TY - JOUR

T1 - Adenosine receptors as targets for therapeutic intervention

AU - Suvarna, B.

PY - 2013/1/1

Y1 - 2013/1/1

N2 - Adenosine receptors are major targets of caffeine, the most commonly consumed drug in the world. There is growing evidence that they could also be promising therapeutic targets in a wide range of conditions, including cerebral and cardiac ischaemic diseases, sleep disorders, immune and inflammatory disorders and cancer. After more than three decades of medicinal chemistry research, a considerable number of selective agonists and antagonists of adenosine receptors have been discovered, and some have been clinically evaluated, although none has yet received regulatory approval. However, recent advances in the understanding of the roles of the various adenosine receptor subtypes, and in the development of selective and potent ligands, as discussed in this review, have brought the goal of therapeutic application of adenosine receptor modulators considerably closer.

AB - Adenosine receptors are major targets of caffeine, the most commonly consumed drug in the world. There is growing evidence that they could also be promising therapeutic targets in a wide range of conditions, including cerebral and cardiac ischaemic diseases, sleep disorders, immune and inflammatory disorders and cancer. After more than three decades of medicinal chemistry research, a considerable number of selective agonists and antagonists of adenosine receptors have been discovered, and some have been clinically evaluated, although none has yet received regulatory approval. However, recent advances in the understanding of the roles of the various adenosine receptor subtypes, and in the development of selective and potent ligands, as discussed in this review, have brought the goal of therapeutic application of adenosine receptor modulators considerably closer.

UR - http://www.scopus.com/inward/record.url?scp=84879265666&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84879265666&partnerID=8YFLogxK

M3 - Article

VL - 11

SP - 96

EP - 101

JO - Kathmandu University Medical Journal

JF - Kathmandu University Medical Journal

SN - 1812-2027

IS - 41

ER -